News | January 08, 2024
Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr
Arco Lab now holds a 50% stake in Neviton
Arco Lab now holds a 50% stake in Neviton
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Development services for gene and cell therapies is planned to begin first in 2025
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Expands patient reach to remotest towns by furthering investment in GoApptiv
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
New facility is part of Aptar Pharma’s global expansion program
This cell will serve as an extension of the Tele Mental Health Assistance and Networking Across States initiative of the Ministry of Health and Family welfare
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Subscribe To Our Newsletter & Stay Updated
